Related Experiment Videos
Association between Diabetes-Related Distress and Medication Adherence among Patients with Type 2 Diabetes Mellitus,
Michael Adeyemi Olamoyegun1, Olubukola Ayoola Ojo2, Akinyele Taofiq Akinlade3
1Department of Medicine, Endocrinology, Diabetes & Metabolism (EDM) Unit, Ladoke Akintola University of Technology/LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Nigeria.
Background:
Diabetes-related distress is a common complication that usually impacts the well-being, health outcomes and adherence to medications, especially in individuals with type 2 diabetes mellitus (T2DM). Hence, this study aimed to estimate diabetes-related-distress and its association with medication adherence.
Methodology:
This is a hospital-based cross-sectional study conducted among 135 patients with T2DM recruited consecutively from a diabetes clinic of a tertiary health institution, Southwest, Nigeria, from March to September 2022. Data were obtained using the Diabetes Distress Scale (DSS-17) questionnaire and Morisky's Medication Adherence Scale (MMAS-8). The association between the dependent variable (DRD) and the independent variable (medication adherence) was assessed with chi-square, and predictors of DSS with logistic regression analysis. The ethical approval was obtained from the committee of the hospital.
Results:
The mean age of study participants, and duration of diabetes were 62.20 ± 12.80 years and 7.96 ±7.01 years, respectively. The proportion of diabetes distress among the study population was 30.5% (8.3 % had high distress and 22.2 % moderate distress). Poor adherence to medications was 66.5%. The study showed that diabetes-related distress was associated with poor medication adherence ( χ2 =9.251, p=0.010). Patients who were highly distressed had 56% lower odds of adhering to their medications compared to those who were not (OR: 0.32, 95% CI: 0.15-0.62).
Conclusion:
Our findings suggest that diabetes distress is a common issue and significantly determines medication adherence. Thus, incorporating routine screening for distress into the standard diabetes care will be an important intervention to improve adherence and health outcomes of people living with T2DM.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations